Comprehensive biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers

被引：0
|
作者：
Spoerke, Jill M. [1 ]
Schleifman, Erica B. [1 ]
Desai, Rupal [1 ]
Xiao, Yuanyuan [1 ]
Wong, Cheryl [1 ]
Abbas, Ilma [1 ]
O'Brien, Carol [1 ]
Patel, Rajesh [1 ]
Sumiyoshi, Teiko [1 ]
Fu, Ling [1 ]
Tam, Rachel [1 ]
Koeppen, Hartmut [1 ]
Wilson, Timothy [1 ]
Raja, Rajiv [1 ]
Hampton, Garret M. [1 ]
Lackner, Mark R. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
MOLECULAR CANCER RESEARCH | 2013年 / 11卷
关键词：
D O I：
10.1158/1557-3125.ADVBC-B024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B024
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeted Biomarker Profiling of Matched Primary and Metastatic Estrogen Receptor Positive Breast Cancers
    Schleifman, Erica B.
    Desai, Rupal
    Spoerke, Jill M.
    Xiao, Yuanyuan
    Wong, Cheryl
    Abbas, Ilma
    O'Brien, Carol
    Patel, Rajesh
    Sumiyoshi, Teiko
    Fu, Ling
    Tam, Rachel N.
    Koeppen, Hartmut
    Wilson, Timothy R.
    Raja, Rajiv
    Hampton, Garret M.
    Lackner, Mark R.
    PLOS ONE, 2014, 9 (02):
  • [2] Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
    Fumagalli, D.
    Wilson, T. R.
    Salgado, R.
    Lu, X.
    Yu, J.
    O'Brien, C.
    Walter, K.
    Huw, L. Y.
    Criscitiello, C.
    Laios, I.
    Jose, V.
    Brown, D. N.
    Rothe, F.
    Maetens, M.
    Zardavas, D.
    Savas, P.
    Larsimont, D.
    Piccart-Gebhart, M. J.
    Michiels, S.
    Lackner, M. R.
    Sotiriou, C.
    Loi, S.
    ANNALS OF ONCOLOGY, 2016, 27 (10) : 1860 - 1866
  • [3] Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor
    Brandon S. Sheffield
    Zuzana Kos
    Karama Asleh-Aburaya
    Xiu Qing Wang
    Samuel Leung
    Dongxia Gao
    Jennifer Won
    Christine Chow
    Rakesh Rachamadugu
    Inge Stijleman
    Robert Wolber
    C. Blake Gilks
    Nickolas Myles
    Tom Thomson
    Malcolm M. Hayes
    Philip S. Bernard
    Torsten O. Nielsen
    Stephen K. L. Chia
    Breast Cancer Research and Treatment, 2016, 155 : 483 - 490
  • [4] Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor
    Sheffield, Brandon S.
    Kos, Zuzana
    Asleh-Aburaya, Karama
    Wang, Xiu Qing
    Leung, Samuel
    Gao, Dongxia
    Won, Jennifer
    Chow, Christine
    Rachamadugu, Rakesh
    Stijleman, Inge
    Wolber, Robert
    Gilks, C. Blake
    Myles, Nickolas
    Thomson, Tom
    Hayes, Malcolm M.
    Bernard, Philip S.
    Nielsen, Torsten O.
    Chia, Stephen K. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 483 - 490
  • [5] Therapeutic Potential of Combining Eltanexor with Tamoxifen to Treat Primary and Metastatic Estrogen Receptor Positive (ER plus ) Breast Cancers
    Jain, Vedant
    Kamdar, Myra
    Mcgee, Hannah
    Zuo, Qianying
    Yoo, Jin Young
    Landesman, Yosef
    Walker, Christopher
    Madak-Erdogan, Zeynep
    CANCER RESEARCH, 2024, 84 (09)
  • [6] ZIRA: A new prognostic biomarker of estrogen receptor- positive (ER plus ) breast cancers
    Vendrell, J.
    Nguyen, N. T.
    Gyorffy, B.
    Leon, S.
    Grisard, E.
    Bachelot, T.
    Treilleux, I.
    Cohen, P. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S155 - S155
  • [7] Patterns of acquired mutations in estrogen receptor-positive metastatic breast cancer (MBC) patients identified by comprehensive genomic profiling (CGP)
    McGregor, K.
    Ross, J. S.
    Danziger, N. A.
    Sokol, E. S.
    Venstrom, J.
    Chung, J. H.
    Lee, J.
    Alexander, B.
    Schrock, A. B.
    Tukachinsky, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S364 - S364
  • [8] WHY ARE ESTROGEN-RECEPTOR-NEGATIVE BREAST CANCERS MORE AGGRESSIVE THAN THE ESTROGEN-RECEPTOR-POSITIVE BREAST CANCERS
    SHEIKH, MS
    GARCIA, M
    PUJOL, P
    FONTANA, JA
    ROCHEFORT, H
    INVASION & METASTASIS, 1994, 14 (1-6): : 329 - 336
  • [9] Serum proteomic profiling distinguishes estrogen receptor (ER) positive and ER negative breast cancers.
    Sun, M
    Sun, M
    Lyons-Weiler, J
    Lokshin, AE
    Modugno, F
    Marks, J
    Bigbee, WL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 23S - 23S
  • [10] Discordance in estrogen receptor status between primary, metastatic, and second primary breast cancers: Impact of misclassification.
    Huo, D.
    Liu, J.
    Olopade, O. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345